AnHorn Medicines
Taipei
About AnHorn Medicines
AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2023)
- Website: anhornmed.com
- Phone: [email protected]
Industries & Categories
Medical, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/anhorn-medicines-12077 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.